|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 25-30, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
J Butler, D Parker, R Pillai, S Westaby, DJ Shale and GM Rocker
Leukocyte counts, plasma neutrophil elastase, tumor necrosis factor- alpha
and C-reactive protein were determined serially in 19 patients undergoing
elective coronary artery surgery with cardiopulmonary bypass. Neutrophil
counts (mean +/- standard deviation 3.85 +/- 1.20 x 10(9)/L preoperatively)
peaked 4 hours postoperatively at 10.35 +/- 4.24 x 10(9)/L (p < 0.001)
and remained significantly elevated 48 hours postoperatively at 7.80 +/-
2.70 x 10(9)/L, p < 0.05. Plasma neutrophil elastase level (187 +/- 74
ng/ml preoperatively) peaked at 698 +/- 323 ng/ml at the end of surgery (p
< 0.001) and remained significantly elevated at 424 +/- 146 ng/ml 48
hours postoperatively (p < 0.01). Peak elastase levels correlated
significantly with duration of bypass (r = 0.47, n = 19, p < 0.05).
Monocyte counts (0.29 +/- 0.19 x 10(9)/L preoperatively) peaked 4 hours
postoperatively (0.87 +/- 0.41 x 10(9)/L, p < 0.001) and fell to
baseline levels by 48 hours postoperatively. Plasma tumor necrosis
factor-alpha, detectable in 10 of the 19 patients preoperatively (median
0.39 U/ml, range up to 10.1 U/ml), did not change significantly during or
after bypass. Plasma C- reactive protein level (median 1.67 [range 0.69 to
34.33] micrograms/ml preoperatively) rose significantly to 3.99 (range 1.95
to 12.55) micrograms/ml 4 hours postoperatively (p < 0.01) and rose 48
hours postoperatively at 303 (210 to 410) micrograms/ml, p < 0.001.
Oxygenation, determined by the respiratory index, was impaired at the end
of operation (2.07 +/- 0.82) and remained impaired 24 hours postoperatively
(2.48 +/- 0.83). Impairment of oxygenation was temporally related to
elevated elastase levels, but neither peak elastase levels nor the change
in elastase levels with lung reperfusion correlated significantly with the
area under the respiratory index curve up to 6 hours postoperatively. This
study demonstrates neutrophil elastase release during cardiopulmonary
bypass but fails to show a definite role for neutrophil activation or tumor
necrosis factor-alpha in the etiology of pulmonary dysfunction after
cardiopulmonary bypass.
ARTICLES
Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor [published erratum appears in J Thorac Cardiovasc Surg 1993 Jun;105(6):1056]
Department of Cardiothoracic Surgery, Oxford Heart Centre, John Radcliffe Hospital, England.
This article has been cited by other articles:
![]() |
M. E. Jessen Pro: Heparin-Coated Circuits Should be Used for Cardiopulmonary Bypass Anesth. Analg., December 1, 2006; 103(6): 1365 - 1369. [Full Text] [PDF] |
||||
![]() |
B. Lo, R. Fijnheer, A. P. Nierich, P. Bruins, and C. J. Kalkman C-Reactive Protein is a Risk Indicator for Atrial Fibrillation After Myocardial Revascularization Ann. Thorac. Surg., May 1, 2005; 79(5): 1530 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cagli, M. M. Ulas, K. Ozisik, A. Kale, V. Bakuy, M. Emir, M. Balci, M. Topbas, E. Sener, and O. Tasdemir The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass Perfusion, January 1, 2005; 20(1): 45 - 51. [Abstract] [PDF] |
||||
![]() |
G. J Murphy, R. Ascione, and G. D Angelini Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur. Heart J., December 1, 2004; 25(23): 2077 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Tang, Y J Gu, W J Wang, Y P Xu, and C Z Chen Effect of cardiopulmonary bypass on leukocyte activation: changes in membrane-bound elastase on neutrophils Perfusion, March 1, 2004; 19(2): 93 - 99. [Abstract] [PDF] |
||||
![]() |
S. Mirsadraee, A. Fraser, M. A Kerr, T. E James, and C. van Doorn Inflammatory response in an immunosuppressed patient with Wegener's granulomatosis Perfusion, March 1, 2004; 19(2): 127 - 131. [Abstract] [PDF] |
||||
![]() |
A. J. Chong, C. R. Hampton, and E. D. Verrier Microvascular Inflammatory Response in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 333 - 354. [Abstract] [PDF] |
||||
![]() |
J. M. Costello, C. L. Backer, A. de Hoyos, H. J. Binns, and C. Mavroudis Aprotinin reduces operative closure time and blood product use after pediatric bypass Ann. Thorac. Surg., April 1, 2003; 75(4): 1261 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Ascione and G.D Angelini OPCAB surgery: a voyage of discovery back to the future Eur. Heart J., January 2, 2003; 24(2): 121 - 124. [Full Text] [PDF] |
||||
![]() |
R. Ascione, M. Caputo, and G. D. Angelini Off-pump coronary artery bypass grafting: not a flash in the pan Ann. Thorac. Surg., January 1, 2003; 75(1): 306 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sason-Ton, R. Ben Abraham, D. Lotan, O. Dagan, T. Prince, Z. Barzilay, and G. Paret Tumor necrosis factor and clinical and metabolic courses after cardiac surgery in children J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 991 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Gu, P. Schoen, I. Tigchelaar, B. G. Loef, T. Ebels, A. J. Rankin, and W. van Oeveren Increased neutrophil priming and sensitization before commencing cardiopulmonary bypass in cardiac surgical patients Ann. Thorac. Surg., October 1, 2002; 74(4): 1173 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Butler, E. W. Murithi, V. L. Pathi, K. J.D. MacArthur, and G. A. Berg Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function Ann. Thorac. Surg., July 1, 2002; 74(1): 139 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ascione, S. Al-Ruzzeh, K. Amer, and G. D Angelini Subsystem organ function during coronary surgery Perfusion, July 1, 2002; 17(4): 295 - 303. [Abstract] [PDF] |
||||
![]() |
G. Asimakopoulos, E. A. Lidington, J. Mason, D. O. Haskard, K. M. Taylor, and R. C. Landis Effect of aprotinin on endothelial cell activation J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Mojcik and J. H. Levy Aprotinin and the systemic inflammatory response after cardiopulmonary bypass Ann. Thorac. Surg., February 1, 2001; 71(2): 745 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fabbri, J. Manfredi, C. Piccin, G. Soffiati, M. R. Carta, E. Gasparotto, and G. Nardon Systemic leukocyte filtration during cardiopulmonary bypass Perfusion, January 1, 2001; 16(1_suppl): 11 - 18. [Abstract] [PDF] |
||||
![]() |
R. Ascione, C. T. Lloyd, M. J. Underwood, A. A. Lotto, A. A. Pitsis, and G. D. Angelini Inflammatory response after coronary revascularization with or without cardiopulmonary bypass Ann. Thorac. Surg., April 1, 2000; 69(4): 1198 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Birdi, M. Caputo, M. Underwood, A.J. Bryan, and G.D. Angelini The effects of cardiopulmonary bypass temperature on inflammatory response following cardiopulmonary bypass Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 540 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chello, P. Mastroroberto, F. Cirillo, E. Bevacqua, A. Carrano, F. Perticone, and A. R. Marchese Neutrophil-endothelial cells modulation in diabetic patients undergoing coronary artery bypass grafting Eur. J. Cardiothorac. Surg., October 1, 1999; 14(4): 373 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Azzawi and P. Hasleton Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease Cardiovasc Res, September 1, 1999; 43(4): 850 - 859. [Full Text] [PDF] |
||||
![]() |
D. E. Carney, C. J. Lutz, A. L. Picone, L. A. Gatto, N. S. Ramamurthy, L. M. Golub, S. R. Simon, B. Searles, A. Paskanik, K. Snyder, et al. Matrix Metalloproteinase Inhibitor Prevents Acute Lung Injury After Cardiopulmonary Bypass Circulation, July 27, 1999; 100(4): 400 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashraf, K. Bhattacharya, Y. Tian, and K. Watterson Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest Eur. J. Cardiothorac. Surg., July 1, 1999; 16(1): 32 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Gu, P. W. Boonstra, and W. van Oeveren Effect of normoxic cardiopulmonary bypass on leukocyte elastase release J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1045 - 1046. [Full Text] |
||||
![]() |
K. Ihnken Reply J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1046 - 1046. [Full Text] |
||||
![]() |
G. M. Tsang, S. Allen, D. Pagano, C. Wong, T. R Graham, and R. S Bonser von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 385 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jahangiri, I. B. Kovacs, C. D. Ridler, G. M. Rees, and P. Gorog Coronary artery surgery is associated with different forms of atherogenic lipoprotein modifications Ann. Thorac. Surg., March 1, 1999; 67(3): 652 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Asimakopoulos and K. M. Taylor Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules Ann. Thorac. Surg., December 1, 1998; 66(6): 2135 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bando, M. W. Turrentine, P. Vijay, T. G. Sharp, Y. Sekine, B. J. Lalone, L. Szekely, and J. W. Brown Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease Ann. Thorac. Surg., September 1, 1998; 66(3): 821 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, H. M. Huang, De Ming Zhu, H. Chen, Z. K. Su, and W. X. Ding Modified ultrafiltration in paediatric cardiopulmonary bypass Perfusion, September 1, 1998; 13(5): 304 - 310. [Abstract] [PDF] |
||||
![]() |
K. Ihnken, A. Winkler, C. Schlensak, K. Sarai, G. Neidhart, U. Unkelbach, A. Mulsch, and A. Sewell Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 327 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Mainwaring, J. J. Lamberti, and T. E. Hugli Complement Activation and Cytokine Generation After Modified Fontan Procedure Ann. Thorac. Surg., June 1, 1998; 65(6): 1715 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashraf, J. Butler, Y. Tian, D. Cowan, S. Lintin, N. R. Saunders, K. G. Watterson, and P. G. Martin Inflammatory Mediators in Adults Undergoing Cardiopulmonary Bypass: Comparison of Centrifugal and Roller Pumps Ann. Thorac. Surg., February 1, 1998; 65(2): 480 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chiba, K. Morioka, R. Muraoka, A. Ihaya, T. Kimura, T. Uesaka, T. Tsuda, and K. Matsuyama Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass Ann. Thorac. Surg., January 1, 1998; 65(1): 107 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bruins, H. t. Velthuis, A. P. Yazdanbakhsh, P. G. M. Jansen, F. W. J. van Hardevelt, E. M. F. H. de Beaumont, C. R. H. Wildevuur, L. Eijsman, A. Trouwborst, and C. E. Hack Activation of the Complement System During and After Cardiopulmonary Bypass Surgery : Postsurgery Activation Involves C-Reactive Protein and Is Associated With Postoperative Arrhythmia Circulation, November 18, 1997; 96(10): 3542 - 3548. [Abstract] [Full Text] |
||||
![]() |
M. TSUCHIDA, H. WATANABE, T. WATANABE, H. HIRAHARA, M. HAGA, H. OHZEKI, J. HAYASHI, H. MIYAMURA, T. HIRONO, T. ABO, et al. Effect of Cardiopulmonary Bypass on Cytokine Release and Adhesion Molecule Expression in Alveolar Macrophages . Preliminary Report In Six Cases Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 932 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Butler, V. L. Pathi, R. D. Paton, R. W. Logan, K. J. D. MacArthur, M. P. G. Jamieson, and J. C. S. Pollock Acute-Phase Responses to Cardiopulmonary Bypass in Children Weighing Less Than 10 Kilograms Ann. Thorac. Surg., August 1, 1996; 62(2): 538 - 542. [Abstract] [Full Text] |
||||
![]() |
M. C. Deng, B. Dasch, M. Erren, T. Mollhoff, and H. H. Scheld Impact of Left Ventricular Dysfunction on Cytokines, Hemodynamics, and Outcome in Bypass Grafting Ann. Thorac. Surg., July 1, 1996; 62(1): 184 - 190. [Abstract] [Full Text] |
||||
![]() |
M.-C. Seghaye, J. Duchateau, R. G. Grabitz, J. Mertes, C. Marcus, K. Buro, B. J. Messmer, and G. von Bernuth HISTAMINE LIBERATION RELATED TO CARDIOPULMONARY BYPASS IN CHILDREN: POSSIBLE RELATION TO TRANSIENT POSTOPERATIVE ARRHYTHMIAS J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 971 - 981. [Abstract] [Full Text] |
||||
![]() |
S. Allen Leucocyte depletion in cardiothoracic surgery Perfusion, May 1, 1996; 11(3): 270 - 277. [PDF] |
||||
![]() |
I. Birdi, M. B. Izzat, A. J. Bryan, and G. D. Angelini Normothermic Techniques During Open Heart Operations Ann. Thorac. Surg., May 1, 1996; 61(5): 1573 - 1580. [Abstract] [Full Text] |
||||
![]() |
M.-C. Seghaye, MD, J. Duchateau, R. G. Grabitz, T. Wolffb, C. Marcus, W. Engelhardt, H. Hornchen, B. J. Messmer, and G. von Bernuth EFFECT OF SODIUM NITROPRUSSIDE ON COMPLEMENT ACTIVATION INDUCED BY CARDIOPULMONARY BYPASS: A CLINICAL AND EXPERIMENTAL STUDY J. Thorac. Cardiovasc. Surg., April 1, 1996; 111(4): 882 - 892. [Abstract] [Full Text] |
||||
![]() |
M.-J. Wang, I.-S. Chiu, C.-M. Hsu, C.-M. Wang, P.-L. Lin, C.-I Chang, C.-H. Huang, and S.-H. Chu Efficacy of Ultrafiltration in Removing Inflammatory Mediators During Pediatric Cardiac Operations Ann. Thorac. Surg., February 1, 1996; 61(2): 651 - 656. [Abstract] [Full Text] |
||||
![]() |
P. Menasche, J. Peynet, N. Haeffner-Cavaillon, M.-P. Carreno, T. de Chaumaray, V. Dillisse, B. Faris, A. Piwnica, G. Bloch, and A. Tedgui Influence of Temperature on Neutrophil Trafficking During Clinical Cardiopulmonary Bypass Circulation, November 1, 1995; 92(9): 334 - 340. [Abstract] [Full Text] |
||||
![]() |
K. H.T. Teoh, C. A. Bradley, J. Gauldie, and H. Burrows Steroid Inhibition of Cytokine-Mediated Vasodilation After Warm Heart Surgery Circulation, November 1, 1995; 92(9): 347 - 353. [Abstract] [Full Text] |
||||
![]() |
P. G. M. Jansen, H. t. Velthuis, R. A. J. M. Huybregts, R. Paulus, E. R. Bulder, H. I. van der Spoel, P. D. Bezemer, E. H. Slaats, L. Eijsman, and C. R. H. Wildevuur Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 829 - 834. [Abstract] [Full Text] |
||||
![]() |
T. Mihaljevic, M. Tonz, L. K. von Segesser, M. Pasic, P. Grob, J. Fehr, B. Seifert, and M. Turina The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1138 - 1145. [Abstract] [Full Text] |
||||
![]() |
H. A. Hennein, H. Ebba, J. L. Rodriguez, S. H. Merrick, F. M. Keith, M. H. Bronstein, J. M. Leung, D. T. Mangano, L. J. Greenfield, and J. S. Rankin Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 626 - 635. [Abstract] [Full Text] |
||||
![]() |
B. Frering, I. Philip, M. Dehoux, C. Rolland, J. M. Langlois, and J. M. Desmonts Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 636 - 641. [Abstract] [Full Text] |
||||
![]() |
N. K. Gupta, P. G. Martin, C. M. Satur, D. Greenstein, and D. R. Walker Neutrophil elastase release and cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1160 - 1161. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |